ff40097a__Reports___Technology_Reviewed__3
[Report] Recombinant coagulation factor VIIa (rFVIIa) for treatment of bleeding and transient normalization of inr in patients on warfarin anticoagulation [Date] 7/21/2010 [2] Hematology [3] 
Factor VIIa
Center for Evidence-based Practice | Evidence Reports - Technology Reviewed
3